SEC Form 4 · accession 0001127602-18-008395
UNITED THERAPEUTICS Corp · UTHR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul A Mahon
Officer — EVP & General Counsel
Period of report
Feb 21, 2018
Accepted (ET)
Feb 26, 2018 · 4:09 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001082554
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF1,F2 | $146.03 | Feb 21, 2018 | A | 42,940 | A | Mar 15, 2018 | Mar 15, 2027 | Common Stock | 42,940 | 42,940 | D |
| Stock Options | $146.03 | holding | — | — | — | Mar 15, 2018 | Mar 15, 2027 | Common Stock | 75,000 | 75,000 | D |
Explanation of responses
- F1These performance-based stock options were initially awarded on March 15, 2017, subject to a one-year performance condition tied to company-wide milestone performance for 2017, which was determined on February 21, 2018. Number of stock options reported represents the number of options earned based on milestone performance.
- F2These stock options vest in one-third increments on each of March 15, 2018, 2019 and 2020